ACKR2 expression ratio (normal-to-pathological) increased insignificantly up-to score three and subsequently decreased significantly along with increasing malignancy, indicating maximal receptor downregulation in adenomas with the highest potential for malignancy. This evidence concerns the gene ACKR2 and adenoma.